.png&w=3840&q=75)
The Evidence Gap That Doesn’t Close Itself
Real-world evidence is no longer supplemental — it is becoming a requirement for regulatory relevance, payer conversations, and commercial differentiation in MedTech. Yet most companies are still relying on evidence strategies built for a slower era of fixed protocols, long enrollment cycles, and delayed publications, while valuable clinical data generated every day in the OR remains unstructured and unusable. The companies gaining advantage are the ones building continuous, real-time evidence assets from day one of commercialization — turning routine care into actionable regulatory and commercial insight in months, not years.
Read Full Article



.png&w=3840&q=75)


.png&w=3840&q=75)

